| Application no. and date | 04025035.9 (espacenet) (Federated) (European Patent Register), 20041021 | | Patent/reg. no. and date | DK/EP 1541197, 20090318 | | Publication date | 20050615 | | Priority no. and date | EP 03447279, 20031202, EP 04447001, 20040105, EP 04447066, 20040318 | | EP pub. no. and date |
EP 1541197 20050615 | | Effective date | | | Applicant/owner | PharmaNeuroBoost N.V., Alkerstraat 30A
3570 Alken, BE | | Applicant ref. no. | P45697DK01 | | Inventor | Buntinx, Erik, Alkerstraat 28
3750 Alken, BE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/343 (2006.01) , A61K 31/4545 (2006.01) , A61P 25/22 (2006.01) , A61P 25/24 (2006.01) | | Title | Anvendelse af pipamperon og en SNDRI, SNRI eller SSRI til behandling af humørsvingninger eller angstlidelser | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
